Product Information
RITONAVIR 100 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.6067 per EA under NDC 69097065502. Its NADAC has been published 173 times since May 3, 2023.
FDA first approved this application on Jan 15, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097065502
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RITONAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA202573FDA Approved
1/15/2015
TE Code
AB
On Market Since
3/23/2022
Pharmacological Classes
Price Statistics
The NADAC for RITONAVIR 100 MG TABLET has been published 173 times since May 3, 2023, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6067 per EA |
|---|---|
| All-time high | $1.2850 (Sep 13, 2023) |
| All-time low | $0.5881 (Nov 22, 2023) |
| 52-week high | $0.9626 |
| 52-week low | $0.6067 |
| Median price | $0.9122 |
| Average price | $0.8807 |
| Largest weekly change | -44.4% (Nov 22, 2023) |
| Weeks tracked | 173 |
| Tracking since | May 3, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ritonavir 100 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RITONAVIR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RITONAVIR 100 MG TABLET, manufactured by Cipla USA Inc., is $0.6067 per EA (NDC 69097065502), effective Aug 19, 2026.
How has the price of RITONAVIR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for RITONAVIR 100 MG TABLET has declined 39.5%. It has been tracked across 173 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for RITONAVIR 100 MG TABLET?
Since May 3, 2023, the NADAC for RITONAVIR 100 MG TABLET has ranged from a low of $0.5881 (Nov 22, 2023) to a high of $1.2850 (Sep 13, 2023), with a median of $0.9122 per EA.
Are there cheaper alternatives to RITONAVIR 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RITONAVIR 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RITONAVIR 100 MG TABLET?
RITONAVIR 100 MG TABLET (NDC 69097065502) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.